Trial
NCT02930941
Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
—
Condition
Epistaxis
Intervention
Tranexamic Acid
Why stopped
Terminate due to slow enrollment rate.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-30